Duodenal Cancer

Disease Overview

duodenalcarcinomais发lifeinduodenalmucosaofmalignant tumor,isprimarysmallintestinecarcinomain相forrareoftype。duodenalisdigestive道ulcer、tumorofgood发regionposition,butduodenalcarcinomaonlyaccounting fordigestive道malignant tumorof0.3%-0.5%,accounting forsmallintestinemalignant tumorof30%-40%。peak age of onset50-70years old,males略moreinfemales。due toduodenalAnatomypositionSpecial,positioninstomachand空intestineofInterval,againisbileandpancreasfluidof共samePassage,duodenalcarcinomaearly-stagesymptomsnot典type,easyanddigestivetypeulcer、chronicstomachConfused with inflammation,at diagnosismoreasadvanced-stage。


d51e803d-2dbe-4e81-82f5-cb65a6f39cd7.png

Major Causes

Adenomatous polyps:duodenalglandulartumorisimportantofprecancerous lesions,particularlyfamilial adenomatous polyposis(FAP)andPeutz-Jeghers syndromepatients。

chronic inflammation:Crohn's disease、chronicduodenalInflammation,celiac diseaseetc.long-termchronic inflammatory stimulationcanincreasingmalignant transformation risk。

Pancreatic diseases:chronicpancreaticInflammation,pancreaticcatheterinternalPapillacondition黏fluidtypetumor(IPMN)累andduodenaltimeincreased risk。

Anomalous pancreaticobiliary junction:congenitaltypegallbladderpancreatic duct汇combinedifferentnormalcausingpancreasfluidReflux,stimulationduodenalmucosa。

Genetic factors:Lynch syndrome(Lynchcomprehensivesign)、familial adenomatous polyposisetc.genetictypetumorcomprehensivesign。

Dietary habits:highfat、highprotein饮food,Alcohol consumption,Smokingetc.。

Helicobacter pyloriinfection:cancanincreasingincidence risk。

duodenalDiverticulum:long-termstimulationmay lead to恶change。


Common Symptoms

early-stagesymptoms:typicallynosignificantsymptomsormanifestationasnon-特differenttypeupper腹discomfort、digestiveadverse。

upperabdominal pain:the most commonsymptoms,persistentorparoxysmaladdheavy,andadvancefoodhaveclose。

jaundice:Tumor invadesampulla of Vaterorcommon bile ductunderDistal end,causingbiliary tractobstruction,appearingskin, Scleral icterus,small便deepJaundice, clay-colored stools.

digestive道bleeding:manifestationasMelena, hematemesis,oranemia、fatigue, Dizzinessetc.symptoms。

abdominalmass:advanced-stagecaninrightupperAbdominal palpationandmass。

obstructionsymptoms:

obstructive jaundice:biliary tractobstruction

duodenalobstruction:nausea、vomiting、abdominal distension,vomiting含bile

pancreaticobstruction:abdominal pain、steatorrhea、Diabetes

systemicsymptoms:body weightunderdecrease、food欲decreaseretreat、fatigue、feveretc.。


Pathological Classification

glandularcarcinoma(80%-90%):mostcommon,includingpapillary adenocarcinoma、tubular adenocarcinoma、mucinous adenocarcinoma

carcinoid tumor(neuroendocrine tumors):approximately10%-20%,relatively low degree of malignancy

肉tumor:leiomyosarcoma、gastrointestinal stromal tumor(GIST)etc.

lymphatictumor:primaryduodenallymphatictumor

othertype:squamous cell carcinoma、undifferentiated carcinomaetc.

TNM Staging(AJCC8th edition)

Primary Tumor (T)

Tis:Carcinoma in situ

T1:Tumor invadeslamina propriaorsubmucosa

T2:Tumor invadesmuscularis propria

T3:tumorPenetrationmuscularis propria达serosaunderornoperitoneumCoveringofintestine周tissue,<2cm

T4:tumorPenetration through the viscerallayerperitoneumordirectlyinvasionotherorganorstructure

Regional Lymph Nodes (N)

N0:No regional lymph node metastasis

N1:1-3regionallymph nodesmetastasis

N2:≥4regionallymph nodesmetastasis

Distant Metastasis (M)

M0:No distant metastasis

M1:Distant metastasis present


Clinical Stage Grouping

0stage:Tis N0 M0

Ⅰstage:T1-2 N0 M0

Ⅱstage:T3 N0 M0

ⅢAstage:T4 N0 M0

ⅢBstage:anyT N1 M0

ⅢCstage:anyT N2 M0

Ⅳstage:anyTanyN M1


Diagnosis

Laboratory tests:

血normalRoutine:anemia, Albumincellselevated

hepaticfunction:gallbladder红element, Transaminaseenzymeelevated

Tumor markers:CEA、CA19-9canelevated

Imaging studies:

upper gastrointestinal contrast:showduodenalFilling defect, narrowingnarrow

CTorMRI:assessmenttumorsize、invasionextent、lymph nodesmetastasis、distantmetastasis

ultrasoundinternal镜(EUS):assessmenttumordepth of invasion,guidancepuncture biopsy

ERCP(endoscopic retrograde cholangiopancreatography):showgallbladderpancreatic ductobstructioncondition,canproceedbiopsy

internal镜examination:

upper gastrointestinal endoscopy: Direct visualizationobservedtumorformstate, Obtainbiopsy

duodenoscopy:moregoodobservedPapillary regionandduodenaldecreaseregion


Prevention and Follow-up

regularlybodyExamination:high-riskpopulationregularlyperformedstomach镜examination

treatmentprecancerous lesions:resectionAdenomatous polyps,treatmentchronic inflammation

healthy diet:reducehighfat、highproteinfoodintake,moreEat vegetables and fruits

quit smoking and limit alcohol:reduceincidence risk

follow-up:postoperativelyfirst 2 yearsevery 3-6 monthsfollow-up examination,years 3-5every 6 monthsonce,after 5 yearsannuallyonce

Treatment Plan Evaluation Request

EVALUATION OF DIAGNOSIS AND TREATMENT PLAN
Medical Condition